Alsup Laurie Smaldone
CIK 1589602 · last filed 2026-06-26
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.71M
Companies
6
Total Filings
45
Lifetime Open-Market Net
$0
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ARVN | Director | 41,572 | $8.20 | $340.9K | $0 | 8 | 2026-06-26 |
| TBPH | Director | 80,989 | $16.89 | $1.37M | $0 | 10 | 2026-06-16 |
| BB | Director | — | $8.09 | — | $0 | 18 | 2024-06-26 |
| PARDES BIOSCIENCES, INC. (PRDS) Delisted | Director | — | $2.16 | — | $0 | 3 | 2023-08-31 |
| Kinnate Biopharma Inc. (KNTE) Delisted | Director | — | $2.65 | — | $0 | 3 | 2023-06-13 |
| HUMANIGEN, INC (KBIO) Delisted | Director | — | — | — | $0 | 2 | 2015-07-14 |
Recent Filings · Page 3 of 5
45 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-09-16 | PARDES BIOSCIENCES, INC. (PRDS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-09-01 | BB | Grant (A) | — | $0 | EDGAR |
| 2022-06-21 | ARVN | Grant (A) | — | $0 | EDGAR |
| 2022-06-15 | Kinnate Biopharma Inc. (KNTE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-01 | BB | Grant (A) | — | $0 | EDGAR |
| 2022-04-28 | TBPH | Grant (A) | +9,852 | $0 | EDGAR |
| 2022-03-01 | BB | Grant (A) | — | $0 | EDGAR |
| 2021-12-02 | BB | Grant (A) | — | $0 | EDGAR |
| 2021-09-01 | BB | Grant (A) | — | $0 | EDGAR |
| 2021-06-14 | Kinnate Biopharma Inc. (KNTE) Delisted | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.